OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Evaristo Maiello
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Evaristo Maiello
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Showing 16 citing articles:
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions
Denys Bondar, Yevgen Karpichev
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1269-1269
Open Access | Times Cited: 8
Denys Bondar, Yevgen Karpichev
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1269-1269
Open Access | Times Cited: 8
Olaparib-induced hyperglycemia in ovarian cancer patients – a case series analysis of a three-month therapy with a consideration of BMI
Joanna Stanisławiak‐Rudowicz, Edyta Szałek, Barbara Więckowska, et al.
Pharmacological Reports (2025)
Closed Access
Joanna Stanisławiak‐Rudowicz, Edyta Szałek, Barbara Więckowska, et al.
Pharmacological Reports (2025)
Closed Access
Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting
Mauro Francesco Pio Maiorano, Brigida Anna Maiorano, Annalucia Biancofiore, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1261-1261
Open Access | Times Cited: 8
Mauro Francesco Pio Maiorano, Brigida Anna Maiorano, Annalucia Biancofiore, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1261-1261
Open Access | Times Cited: 8
Effect of Polyamorphism on the Morphology, Dissolution, and Stability of Olaparib
Lu Gao, Xia-Lin Dai, Shun-Yu Li, et al.
Crystal Growth & Design (2024) Vol. 24, Iss. 12, pp. 4906-4913
Closed Access | Times Cited: 2
Lu Gao, Xia-Lin Dai, Shun-Yu Li, et al.
Crystal Growth & Design (2024) Vol. 24, Iss. 12, pp. 4906-4913
Closed Access | Times Cited: 2
Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2MUT ovarian Cancer models
Łukasz Biegała, Małgorzata Statkiewicz, Arkadiusz Gajek, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167574-167574
Open Access | Times Cited: 2
Łukasz Biegała, Małgorzata Statkiewicz, Arkadiusz Gajek, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167574-167574
Open Access | Times Cited: 2
Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma
Gaetano Pezzicoli, F. Ciciriello, Vittoria Musci, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 585-585
Open Access | Times Cited: 1
Gaetano Pezzicoli, F. Ciciriello, Vittoria Musci, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 585-585
Open Access | Times Cited: 1
Predictors of germline genetic testing referral and completion in ovarian cancer patients at a Comprehensive Cancer Center
Katherine W. Saylor, Elizabeth Q. Fernandes, Michael Adams, et al.
Gynecologic Oncology (2024) Vol. 186, pp. 53-60
Closed Access | Times Cited: 1
Katherine W. Saylor, Elizabeth Q. Fernandes, Michael Adams, et al.
Gynecologic Oncology (2024) Vol. 186, pp. 53-60
Closed Access | Times Cited: 1
Haematologic outcomes and associated clinical characteristics among patients receiving Olaparib therapy in the UAE: a retrospective chart review
Lina Wahba, Said Abdallah Nabil, Saba Kendakji, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Lina Wahba, Said Abdallah Nabil, Saba Kendakji, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes
Yue Ma, Natisha Field, Tao Xie, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3068-3068
Open Access | Times Cited: 1
Yue Ma, Natisha Field, Tao Xie, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3068-3068
Open Access | Times Cited: 1
PARP15 is a Susceptibility Locus for Clarkson Disease (Monoclonal Gammopathy–Associated Systemic Capillary Leak Syndrome)
Eunice C. Chan, Ararat J. Ablooglu, Chandra C. Ghosh, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 12, pp. 2628-2646
Closed Access | Times Cited: 1
Eunice C. Chan, Ararat J. Ablooglu, Chandra C. Ghosh, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 12, pp. 2628-2646
Closed Access | Times Cited: 1
In Vitro and Circulation Kinetic Studies on π-π-stacked Poly (ɛ-caprolactone)-based Micelles Loaded with Olaparib
Yu Yang, Yingli Wu, Xu-Jin Gong, et al.
Deleted Journal (2024) Vol. 2, Iss. 1, pp. 1-1–9
Open Access
Yu Yang, Yingli Wu, Xu-Jin Gong, et al.
Deleted Journal (2024) Vol. 2, Iss. 1, pp. 1-1–9
Open Access
Analysis of olaparib-induced hyperglycemia during three-month therapy with consideration of BMI of ovarian cancer patients
Joanna Stanisławiak‐Rudowicz, Edyta Szałek, Barbara Więckowska, et al.
Research Square (Research Square) (2024)
Open Access
Joanna Stanisławiak‐Rudowicz, Edyta Szałek, Barbara Więckowska, et al.
Research Square (Research Square) (2024)
Open Access
Lipid droplets: a candidate new research field for epithelial ovarian cancer
Shiro Koizume, Tomoko Takahashi, Yohei Miyagi
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Shiro Koizume, Tomoko Takahashi, Yohei Miyagi
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell lines
Karolina Wojtowicz, Monika Świerczewska, Michał Nowicki, et al.
Advances in Medical Sciences (2023) Vol. 68, Iss. 2, pp. 379-385
Open Access | Times Cited: 1
Karolina Wojtowicz, Monika Świerczewska, Michał Nowicki, et al.
Advances in Medical Sciences (2023) Vol. 68, Iss. 2, pp. 379-385
Open Access | Times Cited: 1
Sodium bicarbonate potentiates the antitumor effects of Olaparib in ovarian cancer via cGMP/PKG-mediated ROS scavenging and M1 macrophage transformation
Xiao Li, Yaoqi Sun, Jing Guo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117509-117509
Open Access
Xiao Li, Yaoqi Sun, Jing Guo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117509-117509
Open Access
Haematological toxicity of PARP inhibitors in advanced ovarian cancer: A systematic review and meta-analysis
Mauro Francesco Pio Maiorano, Vera Loizzi, Brigida Anna Maiorano, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024) Vol. 305, pp. 232-240
Closed Access
Mauro Francesco Pio Maiorano, Vera Loizzi, Brigida Anna Maiorano, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024) Vol. 305, pp. 232-240
Closed Access
